Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials.
about
Breast cancer treatment-induced cardiotoxicity.Temporal influence of endocrine therapy with tamoxifen and chemotherapy on nutritional risk and obesity in breast cancer patients.The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy.Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study.Incidence of comorbidities in women with breast cancer treated with tamoxifen or an aromatase inhibitor: an Australian population-based cohort study.Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review
P2860
Cardiotoxicity of aromatase inhibitors and tamoxifen in postmenopausal women with breast cancer: a systematic review and meta-analysis of randomized controlled trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cardiotoxicity of aromatase in ...... randomized controlled trials.
@ast
Cardiotoxicity of aromatase in ...... randomized controlled trials.
@en
type
label
Cardiotoxicity of aromatase in ...... randomized controlled trials.
@ast
Cardiotoxicity of aromatase in ...... randomized controlled trials.
@en
prefLabel
Cardiotoxicity of aromatase in ...... randomized controlled trials.
@ast
Cardiotoxicity of aromatase in ...... randomized controlled trials.
@en
P2093
P2860
P356
P1433
P1476
Cardiotoxicity of aromatase in ...... f randomized controlled trials
@en
P2093
F Khosrow-Khavar
N Bouganim
S Al-Qurashi
P2860
P304
P356
10.1093/ANNONC/MDW673
P577
2017-03-01T00:00:00Z